Page last updated: 2024-08-24

duloxetine hydrochloride and Idiopathic Parkinson Disease

duloxetine hydrochloride has been researched along with Idiopathic Parkinson Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Bruno, V; Farcy, N; Karnik, V; Zamorano, C1
Nagamine, T1
Ando, R; Iwaki, H; Miyaue, N; Nagai, M; Nishikawa, N; Nomoto, M; Tada, S; Tsujii, T; Yabe, H; Yamanishi, Y1
Arai, A; Baba, M; Funamizu, Y; Haga, R; Kon, T; Nishijima, H; Nunomura, JI; Suzuki, C; Tomiyama, M; Ueno, T1
Buhidma, Y; Duty, S; Leta, V; Malcangio, M; Ray Chaudhuri, K; Rukavina, K; Sportelli, C1
Bandettini di Poggio, M; Bruno, C; Meschini, MC; Nesti, C; Santorelli, FM; Schenone, A1
Avanzino, L; Bonuccelli, U; Caltagirone, C; Ceravolo, R; Dell'Agnello, G; Fabbrini, G; Guadagna, M; Mancini, M; Meco, G; Morgante, F; Pierantozzi, M; Rossi, A; Ruggieri, S; Silvestrini, M; Spezia, R; Stocchi, F; Tessitore, A1
Pae, CU1

Reviews

2 review(s) available for duloxetine hydrochloride and Idiopathic Parkinson Disease

ArticleYear
Current Status of Pain Management in Parkinson's Disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:3

    Topics: Acetylcholine Release Inhibitors; Alanine; Analgesics; Antiparkinson Agents; Apomorphine; Benzylamines; Botulinum Toxins, Type A; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Duloxetine Hydrochloride; Humans; Levodopa; Naloxone; Oxycodone; Pain; Pain Management; Pain Measurement; Pain Threshold; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes

2020
Pain in Parkinson's disease: new concepts in pathogenesis and treatment.
    Current opinion in neurology, 2019, Volume: 32, Issue:4

    Topics: Analgesics; Botulinum Toxins; Chronic Pain; Deep Brain Stimulation; Duloxetine Hydrochloride; Humans; Naloxone; Oxycodone; Pain Management; Parkinson Disease

2019

Trials

3 trial(s) available for duloxetine hydrochloride and Idiopathic Parkinson Disease

ArticleYear
A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease.
    Journal of the neurological sciences, 2020, Jul-15, Volume: 414

    Topics: Dopamine Agents; Double-Blind Method; Duloxetine Hydrochloride; Humans; Pain; Parkinson Disease; Treatment Outcome

2020
Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience.
    Journal of the neurological sciences, 2017, 04-15, Volume: 375

    Topics: Affect; Aged; Antiparkinson Agents; Drug Therapy, Combination; Duloxetine Hydrochloride; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome

2017
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease.
    Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:16

    Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life; Thiophenes; Treatment Outcome

2012

Other Studies

3 other study(ies) available for duloxetine hydrochloride and Idiopathic Parkinson Disease

ArticleYear
Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease.
    Asian journal of psychiatry, 2020, Volume: 50

    Topics: Aged; Depression; Duloxetine Hydrochloride; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease; Serotonin and Noradrenaline Reuptake Inhibitors

2020
Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation.
    BMC medical genetics, 2013, Oct-07, Volume: 14

    Topics: Benzothiazoles; DNA Mutational Analysis; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Dopamine Agonists; Duloxetine Hydrochloride; Dysarthria; Female; Hereditary Sensory and Motor Neuropathy; Humans; Middle Aged; Mitochondria; Ophthalmoplegia; Parkinson Disease; Pramipexole; Thiophenes; Tomography, Emission-Computed, Single-Photon

2013
Use of antidepressants for depression in patients with Parkinson's disease.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:3

    Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Parkinson Disease; Positron-Emission Tomography; Thiophenes

2013